Mutants of desoxycytidine kinase having extended enzymatic...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/01 (2006.01) C12N 9/12 (2006.01) C12N 15/10 (2006.01)

Patent

CA 2444026

The invention relates to a method for artificial in vivo evolution of proteins, said method making it possible to bring about the evolution of a protein X by complementation of a relative protein Y,X and Y both belonging to the same class of enzyme commission (EC) nomenclature or belonging to related classes. The mutants D133E and R104Q of desoxycytidine kinase (DCK) were obtained; both of said mutations result in acquisition of thymidine kinase activity by DCK.

La présente invention se rapporte à un procédé d'évolution artificielle in vivo de protéines, ledit procédé permettant de faire évolue une protéine X par complémentation d'une protéine apparentée Y, X et Y appartenant tous deux à la même classe de la nomenclature enzymatique EC ou à des classes voisines. Les mutants D133E et R104Q de la désoxycytidine kinase (DCK) ont été obtenus, chacune de ces mutations conférant l'acquisition de l'activité thymidine kinase par DCK.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutants of desoxycytidine kinase having extended enzymatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutants of desoxycytidine kinase having extended enzymatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutants of desoxycytidine kinase having extended enzymatic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1989234

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.